Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.

Analysts estimate that Albertsons Companies will report an earnings per share (EPS) of $0.52. Investors in Albertsons ...

Pfizer (PFE) ended the recent trading session at $25.35, demonstrating a -1.17% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.14%.

Tuesday: JPMorgan Chase, Wells Fargo, Citigroup, BlackRock, and Bank of New York Mellon release results. Wednesday: Bank of ...

Pfizer has caught investors’ eyes recently, outperforming its peers slightly but facing modest growth prospects ahead.